Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit CertaraSeptember 5, 2025
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…CertaraSeptember 5, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies Live Events Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies CertaraSeptember 4, 2025
The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape Webinar The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape CertaraSeptember 3, 2025
Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value Webinar Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value CertaraAugust 21, 2025
The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar Webinar The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar CertaraAugust 18, 2025
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Case Study Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…CertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025